0424_SHSO_Treatment of Early Psychosis_Live

August 13, 2024

Description:

This program is intended to improve knowledge about early psychosis and the clinical high-risk for psychosis syndrome, including improvement in making the diagnostic distinction and in selecting an appropriate course of treatment. Understanding the limitations of the high-risk concept when determining interventions for early psychosis in imperative when evaluating the disease. Early interventions should aim to prevent transition to psychosis but also to improve the quality of life and provide early treatment for other psychiatric disorders. This presentation will also cover how early psychosis and the clinical high-risk for psychosis syndrome affects diverse populations. Facilitation staff will encourage discussion of a current study that is occurring worldwide, funded by the NIMH, involving multiple countries, languages, and cultures.

Target Audience

Nurse, Registered (RN)

Physicians (MD or DO)

Psychologists

Other Healthcare Professionals

Students of Health Professions

Learning Objectives

At the conclusion of this activity, learners will be able to:

1) Distinguish between the clinical high-risk syndrome for psychosis and full psychosis based on clinical criteria.

2) State what the rate of transition is from clinical high-risk state to full psychosis, and how it reduces over time.

3) Evaluate the risk/benefits of using antipsychotic medication in clinical high-risk individuals.

4) Recognize predictors of transition to full psychosis in CHR youth, including clinical variables, Brain MRI structure, Cognitive testing, and EEG-based event-related potential measures.

Course summary

Available credit:

1.00 AMA PRA Category 1 Credit™
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Sutter Health designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™ for physicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.
1.00 AMA PRA Category 1 Credit™ Hour(s)
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Sutter Health certifies this Live activity was designated for a maximum of 1.00 AMA PRA Category 1 Credit™ Hour(s). Non-physicians should claim only the credit commensurate with the extent of their participation in the activity.
1.00 ANCC
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This course/program has been awarded 1.00 ANCC contact hour(s). Sutter Health is accredited provider of nursing continuing professional development. Learners should claim only the credit commensurate with the extent of their participation in the activity.
1.00 CA BRN
This activity is approved for 1.00 contact hour(s) by Sutter Health, which is an approved provider by the California Board of Registered Nursing. (Provider Number 17182). Learners should claim only the credit commensurate with the extent of their participation in the activity.
1.00 IPCE
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

Course opens:

08/13/2024

Course expires:

09/13/2024

Event starts:

08/13/2024 - 12:00pm PDT

Event ends:

08/13/2024 - 1:00pm PDT

Cost:

$0.00

Add to calendar:

Rating:

Culturally Appropriate Care Which is Free of Implicit Biases (AB 1195 & 241):

Bridgwater, M. A., Petti, E., Giljen, M., Akouri-Shan, L., DeLuca, J. S., Rakhshan Rouhakhtar, P., ... & Schiffman, J. (2023). Review of factors resulting in systemic biases in the screening, assessment, and treatment of individuals at clinical high-risk for psychosis in the United States. Frontiers in Psychiatry, 14, 1117022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040591/
DeLuca, J. S., Novacek, D. M., Adery, L. H., Herrera, S. N., Landa, Y., Corcoran, C. M., & Walker, E. F. (2022). Equity in mental health services for youth at clinical high risk for psychosis: considering marginalized identities and stressors. Evidence-based practice in child and adolescent mental health, 7(2), 176-197. https://pubmed.ncbi.nlm.nih.gov/35815004/

Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest

No one involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.

– Provider Designee/Verification: Kerri Maya, MSL, RN

Committee Member(s)